NCT02449187已完成1 期
A Randomized, Open-label, Single Dose, Crossover Study to Investigate the Effect of Food on the Pharmacokinetics of JLP-1310 in Healthy Male Volunteers
适应症
干预措施
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 16
- 试验地点
- 1
- 主要终点
- AUC(last)
研究概览
简要总结
A randomized, open-label, single dose, crossover study to investigate the effect of food on the pharmacokinetics of JLP-1310 in healthy male volunteers.
详细描述
A randomized, open-label, single dose, crossover clinical trial.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Crossover
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 19 Years 至 —（Adult, Older Adult）
- 性别
- Male
- 接受健康志愿者
- 是
入选标准
- •Healthy male volunteer, age is over 19 years
- •Body weight is over 55kg, The result of Body Mass Index(BMI) is not less than 17.5 kg/m2 , no more than 30.5 kg/m2
- •Subject who has the ability to comprehend the study objectives, contents and the property of the study drug before participating in the trial
- •Subject who has the ability and willingness to participate the whole period of trial
排除标准
- •Presence of medical history or a concurrent disease that may interfere with treatment and safety assessment or completion of this clinical study, including clinically significant disorders in kidney, liver, cardiovascular system, respiratory system, endocrine system, or neuropsychiatric system.
- •Subjects who are allergic to investigational drug.
- •Subjects who have a medical history which can affect the clinical trial.
- •Hypertension(Systolic BP ≥ 140mmHG or Diastolic BP ≥ 90mmHg), Liver enzyme (AST, ALT) level exceeds the maximum normal range more than one and a half times.
- •History of drug abuse or positive drug screening.
- •Participation in other drug studies within 3 months prior to the drug administration.
- •Whole blood donation within 60 days, blood component donation within 30 days or who got transfusion within 30days.
研究组 & 干预措施
JLP-1310, Fasted followed by fed
Experimental
JLP-1310 dosing in the fasted state followed by fed dosing
Interventions:
Drug: JLP-1310
干预措施: JLP-1310, Fasted followed by fed (Drug)
JLP-1310, Fed followed by fasted
Experimental
JLP-1310 dosing in the fasted state followed by fed dosing
Interventions:
Drug: JLP-1310
干预措施: JLP-1310, Fed followed by fasted (Drug)
结局指标
主要结局
AUC(last)
时间窗: 48 hours from baseline
Cmax
时间窗: 48 hours from baseline
次要结局
- AUC(inf)(48 hours from baseline)
- Tmax(48 hours from baseline)
- T1/2(48 hours from baseline)
- CL/F(48 hours from baseline)
- Vd/F(48 hours from baseline)
研究者
研究点 (1)
Loading locations...
相似试验
已完成
1 期
A Randomized, Open-label, Single-dose, Crossover Clinical Trial to Evaluate the Food Effect on the Pharmacokinetics of Dilatrend SR 64mg Capsule After Oral Administration in Healthy Male VolunteersChronic Stable AnginaNCT01340248Chong Kun Dang Pharmaceutical24
已完成
1 期
To Evaluate Food Effect on the Pharmacokinetics of Rebamipide in Healthy VolunteersHealthy VolunteersNCT04150146Korea Otsuka Pharmaceutical Co., Ltd.24
已完成
1 期
A Study of the Effect of Food on the Pharmacokinetics of Single Dose RO5185426 And the Safety And Efficacy of Continuous Administration in Patients With BRAF V600E Mutation-Positive Metastatic MelanomaMalignant MelanomaNCT01264380Hoffmann-La Roche16
已完成
1 期
Study to Evaluate the Food Effect of TP-05 in Healthy ParticipantsHealthyNCT05720364Tarsus Pharmaceuticals, Inc.42
已完成
1 期
Bioavailability Study of DP-R202 in Healthy Male Volunteers Under Fed ConditionsHealthyNCT01421576Alvogen Korea24